| Dr Dihan Carrol Heron, MD | |
|
2 Pro Health Plz, New Hyde Park, NY 11042-1111 | |
| (516) 390-5760 | |
| Not Available |
| Full Name | Dr Dihan Carrol Heron |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 21 Years |
| Location | 2 Pro Health Plz, New Hyde Park, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902006398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 235210 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Presbyterian Shadyside | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optum Medical Care Pc | 9931013240 | 997 |
News Archive
Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. Five of the most exciting developments in this rapidly advancing field are presented in a series of articles in the June issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc..
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
New evidence from a laboratory study and a pilot clinical trial confirms the promise of a simple treatment for amblyopia, or "lazy eye," according to researchers from the U.S. and China.
Political Studies professor Colin Farrelly wants to see more research into remarkable examples of health - such as why some people live 100 years disease-free.
A new device developed by researchers at MIT and a physician at Connecticut Children's Medical Center could greatly improve doctors' ability to accurately diagnose ear infections.
› Verified 9 days ago
| Entity Name | Optum Medical Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982643003 PECOS PAC ID: 9931013240 Enrollment ID: O20031119000321 |
News Archive
Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. Five of the most exciting developments in this rapidly advancing field are presented in a series of articles in the June issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc..
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
New evidence from a laboratory study and a pilot clinical trial confirms the promise of a simple treatment for amblyopia, or "lazy eye," according to researchers from the U.S. and China.
Political Studies professor Colin Farrelly wants to see more research into remarkable examples of health - such as why some people live 100 years disease-free.
A new device developed by researchers at MIT and a physician at Connecticut Children's Medical Center could greatly improve doctors' ability to accurately diagnose ear infections.
› Verified 9 days ago
| Entity Name | Prohealth Care Associates Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275596280 PECOS PAC ID: 4486544186 Enrollment ID: O20040317000468 |
News Archive
Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. Five of the most exciting developments in this rapidly advancing field are presented in a series of articles in the June issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc..
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
New evidence from a laboratory study and a pilot clinical trial confirms the promise of a simple treatment for amblyopia, or "lazy eye," according to researchers from the U.S. and China.
Political Studies professor Colin Farrelly wants to see more research into remarkable examples of health - such as why some people live 100 years disease-free.
A new device developed by researchers at MIT and a physician at Connecticut Children's Medical Center could greatly improve doctors' ability to accurately diagnose ear infections.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dihan Carrol Heron, MD 2800 Marcus Ave, New Hyde Park, NY 11042-1008 Ph: (516) 622-6000 | Dr Dihan Carrol Heron, MD 2 Pro Health Plz, New Hyde Park, NY 11042-1111 Ph: (516) 390-5760 |
News Archive
Novel tools and methods for delivering therapeutic genes to cells in the central nervous system hold great promise for the development of new treatments to combat incurable neurologic diseases. Five of the most exciting developments in this rapidly advancing field are presented in a series of articles in the June issue of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc..
Amsterdam Molecular Therapeutics, a leader in the field of human gene therapy, announced today that the European Medicines Agency has granted Orphan Drug Designation to AMT's gene therapy product AMT-080 for the treatment of Duchenne muscular dystrophy.
New evidence from a laboratory study and a pilot clinical trial confirms the promise of a simple treatment for amblyopia, or "lazy eye," according to researchers from the U.S. and China.
Political Studies professor Colin Farrelly wants to see more research into remarkable examples of health - such as why some people live 100 years disease-free.
A new device developed by researchers at MIT and a physician at Connecticut Children's Medical Center could greatly improve doctors' ability to accurately diagnose ear infections.
› Verified 9 days ago
Dr. Farheen Hasan, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-7000 | |
Carylann Hadjiyane, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1991 Marcus Ave, Suite 101, New Hyde Park, NY 11042 Phone: 516-365-4949 Fax: 516-365-5462 | |
Paul S. Berg, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2001 Marcus Ave, Suite N204, New Hyde Park, NY 11042 Phone: 516-684-9229 Fax: 516-977-8589 | |
Dr. Michael Jason Levine, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1999 Marcus Ave Ste 220, New Hyde Park, NY 11042 Phone: 516-869-5400 Fax: 516-869-5800 | |
Gisele Wolf-klein, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2800 Marcus Ave, Suite 200, New Hyde Park, NY 11042 Phone: 516-708-2522 Fax: 516-708-2570 | |
Dr. Monty Max Bodenheimer, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3003 New Hyde Park Rd, Ste 406, New Hyde Park, NY 11042 Phone: 516-719-0102 Fax: 516-358-5403 | |
Michael Xin Chen, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 27005 76th Ave, New Hyde Park, NY 11040 Phone: 718-470-3377 |